BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Staging
8 results:

  • 1. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
    Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
    [No Abstract]    [Full Text] [Related]  

  • 2. Optimizing postoperative outcomes following neoadjuvant chemotherapy and mastectomy with immediate reconstruction: A national analysis.
    Thawanyarat K; Johnstone T; Rowley M; Navarro Y; Hinson C; Nazerali RS
    J Surg Oncol; 2023 Apr; 127(5):768-775. PubMed ID: 36602535
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Screening vs staging magnetic resonance imaging-guided core needle breast biopsies: Does MRI indication impact upgrade rate?
    Beaulieu-Jones BR; Ring N; Frazee TE; DiFlorio-Alexander RM; Rosenkranz KM
    Breast J; 2020 Feb; 26(2):216-219. PubMed ID: 31495016
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A single institutional experience of factors affecting successful identification of sentinel lymph node in breast cancer patients.
    Johnson MT; Guidroz JA; Smith BJ; Graham MM; Scott-Conner CE; Sugg SL; Weigel RJ
    Surgery; 2009 Oct; 146(4):671-6; discussion 676-7. PubMed ID: 19789026
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The clinical value of parasternal sentinel node biopsy in breast cancer.
    Leidenius MH; Krogerus LA; Toivonen TS; Leppänen EA; von Smitten KA
    Ann Surg Oncol; 2006 Mar; 13(3):321-6. PubMed ID: 16485152
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sentinel lymph node dissection in breast cancer.
    Bembenek A; Reuhl T; Markwardt J; Schneider U; Schlag PM
    Swiss Surg; 1999; 5(5):217-21. PubMed ID: 10546520
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. staging of breast cancer: what standards should be used in research and clinical practice?
    Ravaioli A; Tassinari D; Pasini G; Polselli A; Papi M; Fattori PP; Pasquini E; Masi A; Alessandrini F; Canuti D; Panzini I; Drudi G
    Ann Oncol; 1998 Nov; 9(11):1173-7. PubMed ID: 9862046
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Gynecologic cancers: preventive examinations and their limits. An analysis of the current staging and percentage distribution based on 2,612 cancers of the 1 January 1983 to 25 November 1985 cumulative statistics of the Society of Swiss Gynecologic Clinics].
    Hochuli E; Benz J; Litschgi M; Marti WK
    Geburtshilfe Frauenheilkd; 1986 May; 46(5):278-83. PubMed ID: 3721158
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.